Search

Your search keyword '"van Ree, R"' showing total 1,101 results

Search Constraints

Start Over You searched for: Author "van Ree, R" Remove constraint Author: "van Ree, R"
1,101 results on '"van Ree, R"'

Search Results

152. Allergen immunotherapy for IgE-mediated food allergy : a systematic review and meta-analysis

153. The urgent need for a harmonized severity scoring system for acute allergic reactions

154. EAACI guidelines on allergen immunotherapy: Executive statement

155. The urgent need for a harmonized severity scoring system for acute allergic reactions

156. Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy

157. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States:An analysis from the EAACI AIT Guidelines Project

158. A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy

159. EAACI Guidelines on allergen immunotherapy:IgE-mediated food allergy

160. Challenges in the implementation of EAACI guidelines on allergen immunotherapy:A global perspective on the regulation of allergen products

161. Challenges in the implementation of the EAACI AIT guidelines:A situational analysis of current provision of allergen immunotherapy

162. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis

163. A new framework for the documentation and interpretation of oral food challenges in population-based and clinical research

164. Supplementary Material for: Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy

165. A multi-center ring trial of allergen analysis using fluorescent multiplex array technology

166. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

167. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

168. Identification of a 62-kDa major allergen from Artemisia pollen as a putative galactose oxidase

169. Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies

170. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

171. Allergen immunotherapy for IgE-mediated food allergy: Protocol for a systematic review

172. EAACI molecular allergology user's guide

173. EAACI Molecular Allergology User's Guide

174. Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy

175. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy

177. Component‐resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy

178. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

180. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

181. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis

182. Erratum : IgE recognition patterns in peanut allergy are age dependent: Perspectives of the EuroPrevall study (Allergy (2015) 70 (391-406))

183. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

184. Abstracts from the Food Allergy and Anaphylaxis Meeting 2016

185. EAACI Guidelines on Allergen Immunotherapy:Prevention of allergy

186. A new framework for the documentation and interpretation of oral food challenges in population-based and clinical research

187. Poster

188. Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy

189. How much is too much? Threshold dose distributions for 5 food allergens

190. Hazelnut allergy across Europe dissected molecularly: A EuroPrevall outpatient clinic survey

191. From the Sugar Platform to biofuels and biochemicals : Final report for the European Commission Directorate-General Energy

192. D5.3 Summary report on how sustainability aspects of introduction bioeconomy value chains are currently considered

193. Framework and Examples for the Life Cycle Based Assessment of Biorefineries in IEA Bioenergy Task 42 Biorefining

194. Harvesting, logistics and upgrading of herbaceous biomass from verges and natural areas for use in thermal conversion : TKI BBE Park Cuijk

195. International Archives of Allergy and Immunology / Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy

196. IgE recognition patterns in peanut allergy are age dependent: Perspectives of the EuroPrevall study

198. Opisthorchis felineus negatively associates with skin test reactivity in Russia-EuroPrevall-International Cooperation study

199. EAACI Molecular Allergology User's Guide

200. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

Catalog

Books, media, physical & digital resources